Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation

Cancer Cell

Volumn 7, Issue 5, 2005, Pages 433-444

  Nilsson, Jonas A ^a,d   Keller, Ulrich B ^a   Baudino, Troy A ^a,b   Yang, Chunying ^a   Norton, Sara ^a   Old, Jennifer A ^a   Nilsson, Lisa M ^a,d   Neale, Geoffrey ^a   Kramer, Debora L ^c   Porter, Carl W ^c   Cleveland, John L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EFLORNITHINE; MYC PROTEIN; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; GENE DELETION; GENE FUNCTION; GENETIC TRANSCRIPTION; LYMPHOMA; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSGENIC MOUSE;

DROMAIUS NOVAEHOLLANDIAE; MUS MUSCULUS;

EID: 21144448938     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.03.036     Document Type: Article

References (61)

1. J.M. Adams, A.W. Harris, C.A. Pinkert, L.M. Corcoran, W.S. Alexander, S. Cory, R.D. Palmiter, and R.L. Brinster The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice Nature 318 1985 533 538
2. D.S. Askew, R.A. Ashmun, B.C. Simmons, and J.L. Cleveland Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis Oncogene 6 1991 1915 1922
3. M. Auvinen, A. Paasinen, L.C. Andersson, and E. Holtta Ornithine decarboxylase activity is critical for cell transformation Nature 360 1992 355 358
4. J. Bartek, and J. Lukas p27 destruction: Cks1 pulls the trigger Nat. Cell Biol. 3 2001 E95 E98
5. T.A. Baudino, K.H. Maclean, J. Brennan, E. Parganas, C. Yang, A. Aslanian, J.A. Lees, C.J. Sherr, M.F. Roussel, and J.L. Cleveland Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss Mol. Cell 11 2003 905 914
6. C. Bello-Fernandez, G. Packham, and J.L. Cleveland The ornithine decarboxylase gene is a transcriptional target of c-Myc Proc. Natl. Acad. Sci. USA 90 1993 7804 7808
7. C. Bouchard, P. Staller, and M. Eilers Control of cell proliferation by Myc Trends Cell Biol. 8 1998 202 206
8. C. Bouchard, K. Thieke, A. Maier, R. Saffrich, J. Hanley-Hyde, W. Ansorge, S. Reed, P. Sicinski, J. Bartek, and M. Eilers Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 EMBO J. 18 1999 5321 5333
9. Y. Chen, D.L. Kramer, P. Diegelman, S. Vujcic, and C.W. Porter Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells Cancer Res. 61 2001 6437 6444
10. S.S. Cohen A Guide to the Polyamines 1997 Oxford University Press New York
11. R. Dalla-Favera, M. Bregni, J. Erikson, D. Patterson, R.C. Gallo, and C.M. Croce Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells Proc. Natl. Acad. Sci. USA 79 1982 7824 7827
12. A. Egle, A.W. Harris, P. Bouillet, and S. Cory Bim is a suppressor of Myc-induced mouse B cell leukemia Proc. Natl. Acad. Sci. USA 101 2004 6164 6169
13. C.M. Eischen, J.D. Weber, M.F. Roussel, C.J. Sherr, and J.L. Cleveland Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis Genes Dev. 13 1999 2658 2669
14. L or Bcl-2 is bypassed during lymphomagenesis Mol. Cell. Biol. 21 2001 5063 5070
15. C.M. Eischen, M.F. Roussel, S.J. Korsmeyer, and J.L. Cleveland Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis Mol. Cell. Biol. 21 2001 7653 7662
16. R.N. Eisenman Deconstructing myc Genes Dev. 15 2001 2023 2030
17. K. Ellwood-Yen, T.G. Graeber, J. Wongvipat, M.L. Iruela-Arispe, J. Zhang, R. Matusik, G.V. Thomas, and C.L. Sawyers Myc-driven murine prostate cancer shares molecular features with human prostate tumors Cancer Cell 4 2003 223 238
18. G.I. Evan, A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock Induction of apoptosis in fibroblasts by c-myc protein Cell 69 1992 119 128
19. D.J. Feith, L.M. Shantz, and A.E. Pegg Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis Cancer Res. 61 2001 6073 6081
20. J.R. Fozard, M.L. Part, N.J. Prakash, J. Grove, P.J. Schechter, A. Sjoerdsma, and J. Koch-Weser L-Ornithine decarboxylase: an essential role in early mammalian embryogenesis Science 208 1980 505 508
21. A.L. Gartel, X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A.L. Tyner Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 Proc. Natl. Acad. Sci. USA 98 2001 4510 4515
22. E.W. Gerner, and F.L. Meyskens Polyamines and cancer: old molecules, new understanding Nat. Rev. Cancer 4 2004 781 792
23. Y. Guo, R.B. Harris, D. Rosson, D. Boorman, and T.G. O'Brien Functional analysis of human ornithine decarboxylase alleles Cancer Res. 60 2000 6314 6317
24. Y. Guo, J.L. Cleveland, and T.G. O'Brien Haploinsufficiency for Odc modifies mouse skin tumor susceptibility Cancer Res. 65 2005 1146 1149
25. S. Herold, M. Wanzel, V. Beuger, C. Frohme, D. Beul, T. Hillukkala, J. Syvaoja, H.P. Saluz, F. Haenel, and M. Eilers Negative regulation of the mammalian UV response by Myc through association with Miz-1 Mol. Cell 10 2002 509 521
26. M. Jain, C. Arvanitis, K. Chu, W. Dewey, E. Leonhardt, M. Trinh, C.D. Sundberg, J.M. Bishop, and D.W. Felsher Sustained loss of a neoplastic phenotype by brief inactivation of MYC Science 297 2002 102 104
27. D.L. Kramer, B.D. Chang, Y. Chen, P. Diegelman, K. Alm, A.R. Black, I.B. Roninson, and C.W. Porter Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype Cancer Res. 61 2001 7754 7762
28. L. Lan, C. Trempus, and S.K. Gilmour Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice Cancer Res. 60 2000 5696 5703
29. M.S. Lindstrom, U. Klangby, and K.G. Wiman p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53 Oncogene 20 2001 2171 2177
30. K.H. Maclean, U.B. Keller, C. Rodriguez-Galindo, J.A. Nilsson, and J.L. Cleveland c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-X(L) Mol. Cell. Biol. 23 2003 7256 7270
31. M.E. Martinez, T.G. O'Brien, K.E. Fultz, N. Babbar, H. Yerushalmi, N. Qu, Y. Guo, D. Boorman, J. Einspahr, D.S. Alberts, and E.W. Gerner Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene Proc. Natl. Acad. Sci. USA 100 2003 7859 7864
32. C.P. Martins, and A. Berns Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis EMBO J. 21 2002 3739 3748
33. L. Megosh, S.K. Gilmour, D. Rosson, A.P. Soler, M. Blessing, J.A. Sawicki, and T.G. O'Brien Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase Cancer Res. 55 1995 4205 4209
34. P.L. Miliani de Marval, E. Macias, R. Rounbehler, P. Sicinski, H. Kiyokawa, D.G. Johnson, C.J. Conti, and M.L. Rodriguez-Puebla Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues Mol. Cell. Biol. 24 2004 7538 7547
35. K.O. Mitchell, M.S. Ricci, T. Miyashita, D.T. Dicker, Z. Jin, J.C. Reed, and W.S. El-Deiry Bax is a transcriptional target and mediator of c-myc-induced apoptosis Cancer Res. 60 2000 6318 6325
36. Y. Murakami, S. Matsufuji, T. Kameji, S. Hayashi, K. Igarashi, T. Tamura, K. Tanaka, and A. Ichihara Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination Nature 360 1992 597 599
37. D.J. Murphy, L.B. Swigart, M.A. Israel, and G.I. Evan Id2 is dispensable for Myc-induced epidermal neoplasia Mol. Cell. Biol. 24 2004 2083 2090
38. J.A. Nilsson, and J.L. Cleveland Myc pathways provoking cell suicide and cancer Oncogene 22 2003 9007 9021
39. J.A. Nilsson, K.H. Maclean, U.B. Keller, H. Pendeville, T.A. Baudino, and J.L. Cleveland Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation Mol. Cell. Biol. 24 2004 1560 1569
40. J.A. Nilsson, L.M. Nilsson, U. Keller, Y. Yokota, K. Boyd, and J.L. Cleveland Id2 is dispensable for Myc-induced lymphomagenesis Cancer Res. 64 2004 7296 7301
41. T.G. O'Brien, L.C. Megosh, G. Gilliard, and A.P. Soler Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin Cancer Res. 57 1997 2630 2637
42. R.C. O'Hagan, M. Ohh, G. David, I.M. de Alboran, F.W. Alt, W.G. Kaelin Jr., and R.A. DePinho Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression Genes Dev. 14 2000 2185 2191
43. J.H. Patel, A.P. Loboda, M.K. Showe, L.C. Showe, and S.B. McMahon Analysis of genomic targets reveals complex functions of MYC Nat. Rev. Cancer 4 2004 562 568
44. S. Pelengaris, T. Littlewood, M. Khan, G. Elia, and G. Evan Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion Mol. Cell 3 1999 565 577
45. S. Pelengaris, M. Khan, and G.I. Evan Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression Cell 109 2002 321 334
46. H. Pendeville, N. Carpino, J.C. Marine, Y. Takahashi, M. Muller, J.A. Martial, and J.L. Cleveland The ornithine decarboxylase gene is essential for cell survival during early murine development Mol. Cell. Biol. 21 2001 6549 6558
47. K.D. Robertson, and P.A. Jones The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53 Mol. Cell. Biol. 18 1998 6457 6473
48. R.J. Rounbehler, P.M. Rogers, C.J. Conti, and D.G. Johnson Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model Cancer Res. 62 2002 3276 3281
49. C.A. Schmitt, M.E. McCurrach, E. de Stanchina, R.R. Wallace-Brodeur, and S.W. Lowe INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53 Genes Dev. 13 1999 2670 2677
50. C.A. Schmitt, J.S. Fridman, M. Yang, E. Baranov, R.M. Hoffman, and S.W. Lowe Dissecting p53 tumor suppressor functions in vivo Cancer Cell 1 2002 289 298
51. N. Seiler, J.G. Delcros, and J.P. Moulinoux Polyamine transport in mammalian cells. An update Int. J. Biochem. Cell Biol. 28 1996 843 861
52. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
53. P. Staller, K. Peukert, A. Kiermaier, J. Seoane, J. Lukas, H. Karsunky, T. Moroy, J. Bartek, J. Massague, F. Hanel, and M. Eilers Repression of p15INK4b expression by Myc through association with Miz-1 Nat. Cell Biol. 3 2001 392 399
54. A. Strasser, A.W. Harris, M.L. Bath, and S. Cory Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 Nature 348 1990 331 333
55. J. Varley TP53, hChk2, and the Li-Fraumeni syndrome Methods Mol. Biol. 222 2003 117 129
56. J. Vlach, S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc EMBO J. 15 1996 6595 6604
57. A.J. Wagner, C. Meyers, L.A. Laimins, and N. Hay c-Myc induces the expression and activity of ornithine decarboxylase Cell Growth Differ. 4 1993 879 883
58. M. Wilda, J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and W. Woessmann Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children Leukemia 18 2004 584 588
59. W. Yang, J. Shen, M. Wu, M. Arsura, M. FitzGerald, Z. Suldan, D.W. Kim, C.S. Hofmann, S. Pianetti, and R. Romieu-Mourez Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc Oncogene 20 2001 1688 1702
60. F. Zindy, C.M. Eischen, D.H. Randle, T. Kamijo, J.L. Cleveland, C.J. Sherr, and M.F. Roussel Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization Genes Dev. 12 1998 2424 2433
61. F. Zindy, R.T. Williams, T.A. Baudino, J.E. Rehg, S.X. Skapek, J.L. Cleveland, M.F. Roussel, and C.J. Sherr Arf tumor suppressor promoter monitors latent oncogenic signals in vivo Proc. Natl. Acad. Sci. USA 100 2003 15930 15935